U

UroGen Pharma, Inc

Develops RTGel-based drug delivery for uro-oncology

Associate Director - Clinical Quality

Regulatory & Quality (Life Sciences)Confirmed live in the last 24 hours
Full-timePrinceton, NJ, USA$160k - $180k /yr

About the Job

Requirements

  • Minimum of 5–7 years of experience in Clinical Quality Assurance, preferably in a pharmaceutical or biotech setting with outsourced trials.
  • Strong understanding of U.S. and international clinical-trial regulations, including ICH E6(R2) and 21 CFR Parts 50, 54, 56, and 312.
  • Proven experience auditing CROs and other clinical vendors.
  • Demonstrated experience preparing for and participating in regulatory agency inspections.
  • Ability to work independently, manage multiple priorities, and meet deadlines in a fast-paced environment.
  • A proactive and strategic mindset focused on risk mitigation and process improvement.
  • Effective verbal and written communication skills, with the ability to influence and collaborate with diverse stakeholders.
  • Fluency in spoken and written English.
  • Experience with electronic Quality Management Systems.
  • Experience in technical and SOP writing.
  • Proficiency in Microsoft Office, including Word, Excel, and PowerPoint.
  • Bachelor's degree in a life-science or health-related field.

Responsibilities

  • Serve as the primary QA point of contact for clinical activities.
  • Provide quality assurance support to clinical development in accordance with GCP regulations.
  • Participate in preparing, reviewing, and approving study-specific plans.
  • Join site monitoring visits.
  • Collaborate with the Clinical Department and external vendors and CROs to monitor trial performance, perform site audits, and address quality deviations promptly.
  • Collaborate with Clinical Operations, Regulatory Affairs, and Data Management to ensure quality throughout the clinical trial lifecycle.
  • Lead the handling and investigation of clinical quality complaints.
  • Perform other related duties as management may require.
  • Participate in evaluating, qualifying, and selecting CROs and other clinical vendors, including vendor audits to ensure compliance with quality agreements, GCP, and applicable regulations.
  • Participate in vendor performance evaluation and quality metrics, identifying and mitigating potential risks.
  • Support development and review or approval of Clinical SOPs to ensure alignment with ICH and FDA regulations and company policies.
  • Ensure the QMS complies with current clinical regulatory standards, including FDA regulations, ICH guidelines, and other relevant standards.
  • Develop, implement, and document risk-based audit plans for clinical trials and vendors.
  • Manage CAPAs for clinical findings.
  • Plan and conduct internal audits of clinical processes and documentation, including the Trial Master File, to ensure accuracy and compliance.
  • Lead preparation for and support regulatory inspections at the company, investigator sites, or CROs.
  • Prepare reports, communicate findings to management, and track implementation of corrective actions.
  • Provide expert guidance and interpretation of GCP regulations to internal teams and external partners.
  • Develop and deliver training on clinical quality and compliance topics to relevant staff as required.
  • Ensure quality assurance support and oversight for computerized systems with GCP impact in UroGen clinical studies according to FDA requirements and other applicable regulations and guidelines.
  • Support GCP computerized systems assessments in cooperation with QA, IT, contractors, and business owners.

Desired Qualifications

  • An advanced degree or certification in Quality Assurance, such as RQAP-GCP.

About the Company

UroGen Pharma, Inc

Develops RTGel-based drug delivery for uro-oncology

UroGen Pharma develops RTGel-based drug-delivery therapies for urothelial and specialty cancers, commercializing products like Jelmyto and ZUSDURI and advancing a pipeline that includes UGN-102, UGN-103, UGN-104, and UGN-301. Its RTGel platform is liquid at cool temperatures and gels at body temperature, allowing chemotherapy to stay at the treatment site longer for local, sustained exposure. The company differentiates itself by delivering established chemotherapy directly to the disease site to reduce systemic exposure and by building a multi-product portfolio focused on urothelial cancers. Its goal is to improve local treatment outcomes and grow a diversified, globally commercial portfolio through ongoing clinical development and partnerships.

Company size
201-500
Company stage
IPO
Headquarters
Princeton, NJ
Founded
2004

Recently Posted Jobs

Explore more opportunities at UroGen Pharma, Inc

See more jobs